Doug Hampton

Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

by

Successful top line results from Phase 2a clinical trial for lead candidate LP-10 Oral Health Scientific Advisory Board established to focus on development of LP-310 for oral lichen planus Late-breaking presentation of Phase 2a study results at the American Urological Association Annual Meeting Manufacturing collaboration agreement with Cook MyoSite in anticipation of Lipella’s forthcoming Investigational … Read more

NeuroSense Completes Enrollment in Phase 2b ALS Clinical Trial

by

The primary efficacy endpoint of PARADIGM, (NCT05357950), is the assessment of ALS-biomarkers to evaluate PrimeC and its biological activity. Secondary endpoints include the clinical outcome measures Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R), Slow Vital Capacity (SVC), and overall survival, as well as safety and tolerability, in addition to a robust battery of additional biomarkers … Read more

Innovaccer Chief Medical Officer David Nace, MD Joins HFMA’s Healthcare Leadership Council

by

Nationally recognized physician executive and healthcare thought leader will serve in strategic advisory role to leading industry society serving more than 100,000 healthcare finance professionals SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Today Innovaccer Inc. announced that Chief Medical Officer David Nace, MD has joined the Healthcare Financial Management Association’s (HFMA) Healthcare Leadership Council (HLC). As … Read more

SilverSneakers Opens Nominations for 2023 Member of the Year

by

Annual awards honor seniors whose commitment to well-being inspires and champions others to live healthier lives as they age CHANDLER, Ariz., May 15, 2023 /PRNewswire/ — SilverSneakers® by Tivity Health®, the nation’s leading community fitness program for older Americans, announced today it is accepting nominations for the 19th annual SilverSneakers Member of the Year Award. … Read more

IceCure to Report First Quarter 2023 Financial & Operational Results on May 22, 2023

by

CAESAREA, Israel, May 15, 2023 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it will release its financial and operational results for the three months ended March 31, 2023 with … Read more

Premenopause, how to spot it?

by

Menopause does not occur suddenly. It is usually preceded by a period of several years of premenopause. What is it about ? How do you know if it has started? It is around the age of about 50 that the majority of women see menopause. This natural process corresponds to the cessation of ovarian follicular … Read more

New Data Published on Biosense Webster QDOT MICRO™ Catheter

by

Showed high clinical success with 86% freedom from symptomatic recurrence1 Temperature control allows for the safe use of higher RF power in short bursts, enhancing efficacy and efficiency without compromising safety1 IRVINE, Calif., May 15, 2023 /PRNewswire/ — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced … Read more

U.S. Renal Care Raises $328 Million of New Capital to Accelerate Growth

by

PLANO, Texas, May 15, 2023 /PRNewswire/ — U.S. Renal Care (USRC or “the Company”), the nation’s largest privately held and fastest growing kidney care provider, today announced that it has successfully raised $328 million in new capital to further accelerate the Company’s growth and expansion plans. The new capital will be invested in programs focused on innovation … Read more